ADAMIS PHARMACEUTICALS CORP's ticker is ADMP and the CUSIP is 00547W208. A total of 49 filers reported holding ADAMIS PHARMACEUTICALS CORP in Q1 2023. The put-call ratio across all filers is 0.08 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $1 | – | 8,930 | +263.0% | 0.00% | – |
| Q4 2022 | $0 | -100.0% | 2,460 | -54.3% | 0.00% | – |
| Q3 2022 | $1,000 | -90.9% | 5,388 | -54.9% | 0.00% | – |
| Q1 2021 | $11,000 | +1000.0% | 11,938 | +1372.0% | 0.00% | – |
| Q2 2019 | $1,000 | -99.0% | 811 | -97.3% | 0.00% | – |
| Q3 2018 | $104,000 | -11.1% | 29,836 | -11.4% | 0.00% | -100.0% |
| Q1 2018 | $117,000 | +3800.0% | 33,668 | +4744.3% | 0.01% | – |
| Q4 2017 | $3,000 | -97.7% | 695 | -97.3% | 0.00% | -100.0% |
| Q3 2017 | $133,000 | +183.0% | 25,466 | +179.2% | 0.01% | +150.0% |
| Q2 2017 | $47,000 | +4.4% | 9,122 | -36.3% | 0.00% | -33.3% |
| Q4 2016 | $45,000 | -53.1% | 14,313 | -49.4% | 0.00% | -57.1% |
| Q3 2016 | $96,000 | +1271.4% | 28,269 | +2314.1% | 0.01% | +600.0% |
| Q1 2016 | $7,000 | -61.1% | 1,171 | -75.2% | 0.00% | -50.0% |
| Q1 2015 | $18,000 | – | 4,713 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Capital CS Group, LLC | 75,669 | $38,000 | 0.04% |
| Founders Capital Management | 18,000 | $9,000 | 0.01% |
| Verdence Capital Advisors LLC | 58,382 | $29,000 | 0.00% |
| WOLFF WIESE MAGANA LLC | 10,740 | $5,000 | 0.00% |
| TWO SIGMA SECURITIES, LLC | 93,669 | $47,000 | 0.00% |
| Affinity Capital Advisors, LLC | 13,180 | $7,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 171,928 | $86,000 | 0.00% |
| B. Riley Wealth Advisors, Inc. | 25,210 | $13,000 | 0.00% |
| EDMOND DE ROTHSCHILD HOLDING S.A. | 100,000 | $50,000 | 0.00% |
| MGO ONE SEVEN LLC | 10,615 | $5,000 | 0.00% |